Brief: Biofrontera Reports Completion Of Clinical Phase Of Pharmacokinetics Study
08/10/2020 16:02
Oct 8 (Reuters) - BIOFRONTERA AG B8FGn.DE :
* AG REPORTS COMPLETION OF CLINICAL PHASE OF
PHARMACOKINETICS
STUDY
* WE EXPECT TO SUBMIT REPORT TO FDA BY END OF YEAR
Source text for Eikon: ID:nPexBcmwda
Further company coverage: B8FGn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million